CRISIL Ratings has upgraded Asarfi Hospital Ltd to 'CRISIL BBB/Stable' from 'CRISIL BBB-/Stable', citing strong operational growth and improved profitability. The company saw operating income rise to Rs 170.31 crore in FY2026, driven by higher bed occupancy in its cancer unit. While the company maintains a solid financial risk profile, investors should note the continued working capital intensity resulting from long-term government receivables.
Asarfi Hospital Credit Rating Upgraded to CRISIL BBB/Stable
Operating Income reached Rs 170.31 crore in FY2026; Profit After Tax hit Rs 17.08 crore.
Reader Takeaway: Strong revenue growth and margin stability drive the rating upgrade, though high debtor days present ongoing liquidity pressure.
What just happened
CRISIL Ratings has upgraded the long-term bank facilities of Asarfi Hospital Ltd to 'CRISIL BBB/Stable' from 'CRISIL BBB-/Stable'. The agency also assigned a short-term rating of 'CRISIL A3+' and increased the total bank loan facility to Rs 60 crore, up from Rs 46.5 crore.
Why this matters
The rating upgrade reflects the company's improved scale of operations and better financial metrics. Asarfi Hospital reported an operating income of Rs 170.31 crore for FY2026, a significant increase from Rs 121.39 crore in the previous fiscal year. The company's focus on its cancer care unit has been a key revenue driver, with unit occupancy rising to 42% in FY2026 from 30% in FY2025.
The backstory
Over the last four fiscal years, Asarfi Hospital has maintained stable operating margins between 20-21%. The company’s capital structure remains comfortable, with gearing ratios kept below 1 time. The interest coverage ratio stood at 8.43 times in FY2026, indicating strong debt-servicing capability.
Risks to watch
The rating agency identified geographic concentration in Dhanbad, Jharkhand, as a primary constraint on growth. Additionally, the business remains working capital intensive, with debtor days exceeding 115 days. This is primarily attributed to payment delays from government schemes and PSUs, which the company must manage to ensure healthy cash flow.
Context metrics
In FY2026, the company recorded a net profit of Rs 17.08 crore with a margin of 9.91%. Adjusted debt-to-net-worth ratio improved slightly to 0.58 times. Bank limit utilization remains moderate at approximately 77% over the last year.
What to track next
Shareholders should monitor the company's ability to diversify its geographic presence beyond Jharkhand and improvements in the cash conversion cycle regarding government-linked receivables.